Monoclonal antibody
Monoclonal antibody
Lonza Partners with Acumen for Alzheimer’s Breakthrough
BIOT
📰 Lonza teams up with Acumen to make sabirnetug, a groundbreaking Alzheimer's therapy, at their New Hampshire facility. 👥 🧪 Sabirnetug targets toxic amyloid beta oligomers, offering hope in the fight against Alzheimer's. 💡 ⏩ Exciting collaboration to speed up Alzheimer's treatment development. Lonza Acumen AlzheimersTherapy Sabirnetug
Breaking: Scientists Struggle with Monoclonal Antibody HCPs
BIOT
📰 Monoclonal Antibody HCP Challenges: Scientists are still facing the challenge of removing host-cell proteins (HCPs) from bioprocesses. ⚗️🔬🧫
